Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Sun Pharma expects to close the acquisition on or before 31 July 2026.

Sun Pharmaceutical Industries has lined up 11 banks, including State Bank of India (SBI), to finance its $11.75 billion ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

The brokerage expects domestic-focused pharma companies to outperform peers exposed to high-value US generic opportunities, ...

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Get Sun Pharmaceutical Industries latest Profit & Loss account, Income Statement, Financial Statements and Sun Pharmaceutical Industries detailed profit and loss accounts including income, expenses, ...

Sun Pharma announced Thursday morning that it is acquiring Concert Pharmaceuticals for $576 million. The Indian-based pharma company will acquire all outstanding shares of the late-stage biotech that ...

Specialty generics company Sun Pharma has completed the merger of Taro. As part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Sun Pharma expects strong cash flows from the combined business to support debt reduction, innovation investments and growth across specialty medicines, women’s health and global markets.

After navigating a series of manufacturing problems in recent months, Sun Pharma has now been forced to respond to an entirely different type of issue. Last week, Mumbai, India-based Sun Pharma ...